Relative Risk Factors and Risk Reduction Due to Improvements in ABCS
| Groups | Relative Population Size (%) | ASCVD Risk at baseline (%) | Contribution to ASCVD reduction (%) |
|---|---|---|---|
| 49.8 | 7.7 | 3.6 |
| 33.9 | 14.9 | 31.1 |
| 1.6 | 17.7 | 4.1 |
| 2.8 | 13.1 | 7.8 |
| 4.2 | 17.2 | 12.2 |
| 7.8 | 24.6 | 41.2 |
| Total | 100 | 10.1 | 100.0 |
Notes: The table shows the relative population size, average ASCVD risk at baseline, and contribution to ASCVD reduction. The contribution to ASCVD reduction for each group is calculated as the change in ASCVD risk relative to the overall change in ASCVD risk.
Abbreviations:
= people in the denominator for cholesterol management and smoking intervention; = people in the denominator for blood pressure control and smoking intervention; = people in the denominator for aspirin prescription, cholesterol management and smoking intervention; = people in the denominator for blood pressure control, cholesterol management and smoking intervention; = people in the denominator for aspirin prescription, blood pressure control, cholesterol management and smoking intervention. ASCVD = atherosclerotic cardiovascular disease.
